home / stock / blph / blph news

BLPH News and Press, Bellerophon Therapeutics Inc. From 05/19/23

Stock Information
Company Name: Bellerophon Therapeutics Inc.
Stock Symbol: BLPH
Market: OTC
Website: bellerophon.com
Menu
BLPH BLPH Quote BLPH Short BLPH News BLPH Articles BLPH Message Board
Get BLPH Alerts

News, Short Squeeze, Breakout and More Instantly...
BLPH - Lucy Scientific, Bioventus top healthcare gainers; Enveric, Elevation among losers

2023-05-19 10:04:48 ET Gainers: Lucy Scientific Discovery ( LSDI ) +51% . Bioventus ( BVS ) +44% . Mallinckrodt ( MNK ) +28% . 180 Life Sciences ( ATNF ) +28% . Stereotaxis ( STXS ) +25% . Losers: Enveric Biosciences ( ENVB ...
BLPH - Phio, Coya top healthcare gainers; Eloxx, Modular Medical among losers

2023-05-16 10:07:34 ET Gainers: Phio Pharmaceuticals ( PHIO ) +30% . Coya Therapeutics ( COYA ) +23% . Nanobiotix ( NBTX ) +12% . Savara ( SVRA ) +12% . Bellerophon Therapeutics ( BLPH ) +11% . Losers: Eloxx Pharmaceutical...

BLPH - Bellerophon Therapeutics GAAP EPS of $0.27, revenue of $5.64M

2023-05-15 17:31:26 ET Bellerophon Therapeutics press release ( NASDAQ: BLPH ): Q1 GAAP EPS of $0.27. Revenue of $5.64M. For further details see: Bellerophon Therapeutics GAAP EPS of $0.27, revenue of $5.64M

BLPH - Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse®; Pivotal Top-line Data Expected in Mid-2023 WARREN, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a c...
BLPH - Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

WARREN, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that the last patient ...

BLPH - AI, BFLY and CLSD among mid-day movers

2023-04-04 12:51:54 ET Gainers: Cardlytics ( CDLX ) +62% . Assure Holdings ( IONM ) +56% . The NFT Gaming Company ( NFTG ) +42% . Bullfrog AI Holdings ( BFRG ) +32% . Bellerophon Therapeutics ( BLPH ) +27% . Austin Gold ( A...

BLPH - Bellerophon Therapeutics GAAP EPS of -$2.08 misses by $0.06

2023-03-31 08:42:17 ET Bellerophon Therapeutics press release ( NASDAQ: BLPH ): FY GAAP EPS of -$2.08 misses by $0.06 . As of December 31, 2022, the Company had unrestricted cash and cash equivalents of $6.9 million, compared to unrestricted cash and cash equivalents o...
BLPH - Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results

Completed Enrollment in INOpulse® REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023 Signed License Agreement with Baylor BioSciences to Commercialize INOpulse® in Greater China Strengthened Balance Sheet Through $5 Million Registered Direct Offering with ...

BLPH - EMAN, LYLT and SOPH among mid-day movers

2023-03-20 13:07:07 ET Gainers: Loyalty Ventures ( LYLT ) +97% . Ambipar Emergency ( AMBI ) +73% . Lifecore Biomedical ( LFCR ) +60% . InMed Pharmaceuticals ( INM ) +43% . New York Community Bancorp ( NYCB ) +32% . Harbor Cus...

BLPH - THMO and RSLS among healthcare movers

2023-03-20 10:29:09 ET Gainers: Lifecore Biomedical ( LFCR ) +41% . Connect Biopharma ( CNTB ) +27% . InMed Pharmaceuticals ( INM ) +21% . ReShape Lifesciences ( RSLS ) +21% . Bellerophon Therapeutics ( BLPH ) +15% . Losers...
Previous 10 Next 10